Abstract:OBJECTIVE To explore whether the hypertension patients with no clinical cognitive impairment manifestations have certain brain dysfunctions. METHODS Twenty-five moderately to severely hypertensive patients, males and females, aged 63.0 +/- 1.6 (60 approximately 65), with a disease history if 5 to 10 years, and 25 sex, age, and educational level-matched healthy persons underwent tests by mini-mental status examination (MMSE) scales, state anxiety inventory (STAI-S) and trait anxiety inventory (STAI-T), and then underwent two functional magnetic resonance imaging (fMRI) studies. In Experiment 1, the subjects were demanded to listen actively to the meaningless words (pseudowords) and in Experiment 2 the subjects listened actively to real words and make the valence (abstract or concrete) of the words in silence. The subjects were told to listen passively the noise from the MR scanners during the resting period, which was used as the control task. The fMRI data were analyzed with statistical parametric mapping (SPM99) software. RESULTS The MMSE score of the patient group was 29.3 +/- 1.1, not significantly different from that of the control group (29.6 +/- 0.5, P > 0.05). The STAI-S score of the patient group was 47 +/- 5.3748, significantly higher than that of the control group (41.6 +/- 4.9777, P < 0.05). The STAI-S score of the patient group was 45 +/- 3, not significantly different from that of the control group (43 +/- 4, t = 1.0619, P = 0.3032). In Experiment 1, the activated patterns and deactivated patterns were nearly similar for the patient and control groups. The activated regions included the bilateral superior temporal lobe, bilateral inferior frontal cortex and supplementary motor areas. In Experiment 2, the activated patterns were also nearly similar for these 2 groups. The regions included the bilateral superior temporal lobe, bilateral inferior frontal cortex, left angular gyrus, bilateral superior frontal cortex, bilateral cerebellum, premotor areas, and supplementary motor areas. The deactivation patterns were similar for the patients and controls both in Experiment 1 and Experiment 2. These regions were medial prefrontal cortex, posterior cingulate and bilateral inferior parietal cortex, which nearly overlapping with the default model network proposed by Raichle et al. However, the activation and deactivation magnitude and extent of the brain were significantly greater for the patients than for the controls both in Experiment 1 and Experiment 2. CONCLUSION Some brain dysfunction may have already existed in patients with moderately to severely hypertension disorders, though their behavior performance scores are within the normal range of ages. The fMRI technique can be a useful tool to detect the preclinical brain abnormalities.

Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension

Quantitative Susceptibility Mapping to Evaluate Brain Iron Deposition and Its Correlation with Physiological Parameters in Hypertensive Patients.

Brain Iron Deposits in Thalamus is an Independent Factor for Depressive Symptoms Based on Quantitative Susceptibility Mapping in an Older Adults Community Population

Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker

Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment—an in vivo susceptibility mapping study

Altered Brain Iron Depositions from Aging to Parkinson's Disease and Alzheimer's Disease: A Quantitative Susceptibility Mapping Study

Altered brain iron depositions from aging to Parkinson's disease and Alzheimer's disease: A quantitative susceptibility mapping study.

Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.

Cerebral Microbleeds Are Associated With Increased Brain Iron and Cognitive Impairment in Patients With Cerebral Small Vessel Disease: A Quantitative Susceptibility Mapping Study

Quantitative susceptibility mapping reveals brain iron accumulation in minimal hepatic encephalopathy: associations with neurocognitive changes

[Brain iron deposition increases in the bilateral substantia nigra of patients with medication-overuse headache: a quantitative susceptibility mapping analysis]

Iron deposition in the precuneus is correlated with mild cognitive impairment in patients with cerebral microbleeds: A quantitative susceptibility mapping study

Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis

Brain Iron Deposition Analysis Using Susceptibility Weighted Imaging and Its Association with Body Iron Level in Patients with Mild Cognitive Impairment.

[Correlation of Cardiovascular Risk Factors with Brain Iron Deposition: A Magnetic Resonance Imaging Study].

Deep gray matters iron deposition is positively associated with white matter hyperintensity in hypertension

Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus

Quantitative susceptibility mapping for iron monitoring of multiple subcortical nuclei in type 2 diabetes mellitus: a systematic review and meta-analysis

Quantitative Susceptibility Mapping in Cognitive Decline: A Review of Technical Aspects and Applications

Alterations in brain iron deposition with progression of late-life depression measured by magnetic resonance imaging (MRI)-based quantitative susceptibility mapping

Assessment of Preclinical Cognition Impairment in Hypertension Patients with Functional Magnetic Resonance Imaging